NCT04682483 Cardiogenic Shock Working Group Registry
| NCT ID | NCT04682483 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tufts Medical Center |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2017-12-04 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2017-12-04 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients must have cardiogenic shock. Cardiogenic shock is defined by at least one of the two categories below: 1. At least 2 of the following concurrently at any point during the index hospitalization: * Cardiac Index \< 2.2 * PAPI \< 1.0 * Cardiac Power Output ≤ 0.6 * MAP \< 60mmHg or a \>30mmHg drop in MAP from baseline * SBP \< 90mmHg or a \>30mmHg drop in SBP from baseline * Pulse \> 100 2. Require at least one acute mechanical circulatory support device, vasopressor or inotrope to maintain values above the above target. Post-cardiotomy patients must meet the inclusion criteria 72 hours after their surgery to be included in this registry.
Contact & Investigator
Reshad Garan, MD
STUDY DIRECTOR
Beth Israel Deaconess Medical Center
Frequently Asked Questions
Who can join the NCT04682483 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04682483 currently recruiting?
Yes, NCT04682483 is actively recruiting participants. Contact the research team at nkapur@tuftsmedicalcenter.org for enrollment information.
Where is the NCT04682483 trial being conducted?
This trial is being conducted at Weston, United States, Chicago, United States, Chicago, United States, Portland, United States and 11 additional locations.
Who is sponsoring the NCT04682483 clinical trial?
NCT04682483 is sponsored by Tufts Medical Center. The principal investigator is Reshad Garan, MD at Beth Israel Deaconess Medical Center. The trial plans to enroll 5,000 participants.